Allogene Therapeutics Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Allogene Therapeutics stock has a consensus rating of "Buy" and an average price target of $8.35. The average 1-year stock price forecast is 269.47% higher than the current stock price, while the lowest is $3.85 (+70.35%) and the highest is $14 (+519.47%).

Price Target: $8.35 (+269.47%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$3.85	$8.35	$9.00	$14
Change	+70.35%	+269.47%	+298.23%	+519.47%

Analyst Ratings

The average analyst rating for Allogene Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	9	10	10	10	10	9
Buy	2	3	3	3	3	3
Hold	2	1	1	1	2	2
Sell	1	1	1	1	0	0
Strong Sell	0	0	0	0	0	0
Total	14	15	15	15	15	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sami Corwin William Blair	William Blair	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 14, 2026
Matthew Biegler Oppenheimer	Oppenheimer	Buy Reiterates $7	Buy	Reiterates	$7	+209.73%	May 14, 2026
Luca Issi RBC Capital	RBC Capital	Buy Maintains $9	Buy	Maintains	$9	+298.23%	May 14, 2026
John Newman Canaccord Genuity	Canaccord Genuity	Buy Maintains $14	Buy	Maintains	$14	+519.47%	May 14, 2026
Biren Amin Piper Sandler	Piper Sandler	Buy Maintains $10	Buy	Maintains	$10	+342.48%	May 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

13.60K

Revenue Next Year

21.80M

from 13.60K

160,234.20%

from 13.60K

EPS This Year

-0.73

from -0.87

EPS Next Year

-0.78

from -0.73

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	114.09M	156.00K	95.00K	22.00K	-	13.60K	21.80M
Revenue Growth	-	-99.86%	-39.10%	-76.84%	-	-	160,234.20%
EPS	-1.34	-2.38	-2.09	-1.32	-0.87	-0.73	-0.78
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	18	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	105,000	147.2M
Avg	13,597	21.8M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	1,082,670.7%
Avg	-	160,234.2%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.54	-0.50
Avg	-0.73	-0.78
Low	-0.96	-1.25

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.